399 related articles for article (PubMed ID: 19008150)
21. Persistence of lymphatic filarial infection in the paediatric population of rural community, after six rounds of annual mass drug administrations.
Sunish IP; Munirathinam A; Kalimuthu M; Ashok Kumar V; Tyagi BK
J Trop Pediatr; 2014 Jun; 60(3):245-8. PubMed ID: 24343822
[TBL] [Abstract][Full Text] [Related]
22. Improving community participation to eliminate lymphatic filariasis in American Samoa.
King JD; Zielinski-Gutierrez E; Pa'au M; Lammie P
Acta Trop; 2011 Sep; 120 Suppl 1():S48-54. PubMed ID: 20932818
[TBL] [Abstract][Full Text] [Related]
23. Impact of single dose of diethylcarbamazine and other antifilarial drug combinations on bancroftian filarial infection variables: assessment after 2 years.
Sunish IP; Rajendran R; Mani TR; Munirathinam A; Reuben R; Dash AP
Parasitol Int; 2006 Sep; 55(3):233-6. PubMed ID: 16807079
[TBL] [Abstract][Full Text] [Related]
24. Elimination of lymphatic filariasis.
Michael E; Malecela-Lazaro MN; Kazura JW
Lancet; 2006 Jul; 368(9533):362-3; author reply 363-4. PubMed ID: 16876654
[No Abstract] [Full Text] [Related]
25. Elimination of lymphatic filariasis in India.
Sabesan S; Ravi R; Das PK
Lancet Infect Dis; 2005 Jan; 5(1):4-5. PubMed ID: 15620551
[No Abstract] [Full Text] [Related]
26. [Lymphatic filariasis].
Sante; 2000; 10(5):360-1. PubMed ID: 11221698
[No Abstract] [Full Text] [Related]
27. Mass drug administration against lymphatic filariasis: experiences from Kozhikode district of Kerala State.
Regu K; Showkath Ali MK; Rajendran R; Koya SM; Ganesh B; Dhariwal AC; Lal S
J Commun Dis; 2006 Dec; 38(4):333-8. PubMed ID: 17913209
[TBL] [Abstract][Full Text] [Related]
28. Progress towards, and challenges for, the elimination of filariasis from Pacific-island communities.
Burkot TR; Taleo G; Toeaso V; Ichimori K
Ann Trop Med Parasitol; 2002 Dec; 96 Suppl 2():S61-9. PubMed ID: 12625919
[TBL] [Abstract][Full Text] [Related]
29. The development of albendazole for lymphatic filariasis.
Horton J
Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S33-40. PubMed ID: 19843396
[TBL] [Abstract][Full Text] [Related]
30. Lymphatic Filariasis.
Madanchi M; Itin P
N Engl J Med; 2024 May; 390(18):e43. PubMed ID: 38708851
[No Abstract] [Full Text] [Related]
31. Introduction of Triple-Drug Therapy for Accelerating Lymphatic Filariasis Elimination in India: Lessons Learned.
Tripathi B; Roy N; Dhingra N
Am J Trop Med Hyg; 2022 May; 106(5_Suppl):29-38. PubMed ID: 35292580
[TBL] [Abstract][Full Text] [Related]
32. Towards elimination of lymphatic filariasis in India.
Das PK; Ramaiah KD; Augustin DJ; Kumar A
Trends Parasitol; 2001 Oct; 17(10):457-60. PubMed ID: 11587940
[TBL] [Abstract][Full Text] [Related]
33. Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
Fischer PU; King CL; Jacobson JA; Weil GJ
PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005163. PubMed ID: 28056015
[No Abstract] [Full Text] [Related]
34. Lymphatic filariasis in Andhra Pradesh paper mill colony, Rajahmundry, after nine rounds of MDA program.
Mukhopadhyay AK
Indian J Public Health; 2010; 54(3):169-70. PubMed ID: 21245590
[No Abstract] [Full Text] [Related]
35. Preventing confusion about side effects in a campaign to eliminate lymphatic filariasis.
Ramaiah KD; Ravi R; Das PK
Trends Parasitol; 2005 Jul; 21(7):307-8. PubMed ID: 15923141
[No Abstract] [Full Text] [Related]
36. Elimination of lymphatic filariasis: do we have the drugs to complete the job?
Bockarie MJ; Deb RM
Curr Opin Infect Dis; 2010 Dec; 23(6):617-20. PubMed ID: 20847694
[TBL] [Abstract][Full Text] [Related]
37. Lymphatic filariasis.
Wkly Epidemiol Rec; 2003 May; 78(20):171-9. PubMed ID: 12808788
[No Abstract] [Full Text] [Related]
38. A rapid method to assess the coverage of the mass drug administration of diethylcarbamazine in the program to eliminate lymphatic filariasis in India.
Babu BV
Southeast Asian J Trop Med Public Health; 2005 Jan; 36(1):44-5. PubMed ID: 15906640
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the program to eliminate lymphatic filariasis in Vanuatu following two years of mass drug administration implementation: results and methodologic approach.
Fraser M; Taleo G; Taleo F; Yaviong J; Amos M; Babu M; Kalkoa M
Am J Trop Med Hyg; 2005 Oct; 73(4):753-8. PubMed ID: 16222021
[TBL] [Abstract][Full Text] [Related]
40. Diethylcarbamazine citrate-fortified salt for lymphatic filariasis elimination in India.
Sabesan S; Krishnamoorthy K; Hoti SL; Subramanian S; Srividya A; Roy N; Jain T; Kumar A; Rahi M
Indian J Med Res; 2022 Mar; 155(3&4):347-355. PubMed ID: 36124509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]